About
eMetagen is a drug discovery company producing new pharmaceuticals from uncultivated soil microorganisms. The company discovers new antibiotics for development with partners and licensees and also markets its Gene and Pathway Banks™ as tools for drug discovery. eMetagen antibiotics target multiply drug-resistant pathogens responsible for widespread community and in-hospital infections.